CDX2 and colorectal carcinoma: To elucidate how CDX2 may promote tumor growth at the metastatic site, we evaluated certain EMT markers in CDX2 knockdown CRC cells because some evidence suggests mesenchymal-epithelial transition (MET) is essential for metastatic tumor colonization in the liver (42, 43).